| Sanofi-Aventis (Suisse) SA - Clexane 100 mg/ml, solution injectable |
| 49456 | | 03 | | Clexane 100 mg/ml | | solution injectable | | B01AB05 | | Enoxaparin | | 19.10.1993 | | |
|
| Composition |
| enoxaparinum natricum 100 mg corresp. 10000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 100 mg |
| | | | Agents auxilliaires |
|---|
| Anti-Xa |
| |
|
|
